TARDYFERON B9 (ferrous sulfate, folic acid), antianaemic

HAEMATOLOGY - FOCUS

Opinions on drugs - Posted on Sep 10 2015

Renewal of inclusion

TARDYFERON B9 has Marketing Authorisation in the preventive treatment of iron and folic acid deficiencies in pregnant women when an adequate dietary intake cannot be guaranteed.
Systematic supplementation is not indicated during pregnancy with a combination of iron and folic acid for the prevention of a possible deficiency.
Only proven iron deficiency needs to be treated with iron and folic acid.